These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 28350091)
1. Clinical implication of Frizzled 2 expression and its association with epithelial-to-mesenchymal transition in hepatocellular carcinoma. Asano T; Yamada S; Fuchs BC; Takami H; Hayashi M; Sugimoto H; Fujii T; Tanabe KK; Kodera Y Int J Oncol; 2017 May; 50(5):1647-1654. PubMed ID: 28350091 [TBL] [Abstract][Full Text] [Related]
2. Frizzled 2-induced epithelial-mesenchymal transition correlates with vasculogenic mimicry, stemness, and Hippo signaling in hepatocellular carcinoma. Ou H; Chen Z; Xiang L; Fang Y; Xu Y; Liu Q; Hu Z; Li X; Huang Y; Yang D Cancer Sci; 2019 Apr; 110(4):1169-1182. PubMed ID: 30677195 [TBL] [Abstract][Full Text] [Related]
3. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092 [TBL] [Abstract][Full Text] [Related]
4. Cx32 reverses epithelial-mesenchymal transition in doxorubicin-resistant hepatocellular carcinoma. Yu M; Han G; Qi B; Wu X Oncol Rep; 2017 Apr; 37(4):2121-2128. PubMed ID: 28260043 [TBL] [Abstract][Full Text] [Related]
5. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells. Zhang C; Guo F; Xu G; Ma J; Shao F Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024 [TBL] [Abstract][Full Text] [Related]
6. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis. Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429 [TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells. Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164 [TBL] [Abstract][Full Text] [Related]
9. TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma. Xiao H; Jiang N; Zhou B; Liu Q; Du C Cancer Sci; 2015 Feb; 106(2):151-9. PubMed ID: 25495189 [TBL] [Abstract][Full Text] [Related]
10. KIAA1217 Promotes Epithelial-Mesenchymal Transition and Hepatocellular Carcinoma Metastasis by Interacting with and Activating STAT3. Wang Y; Li N; Zheng Y; Wang A; Yu C; Song Z; Wang S; Sun Y; Zheng L; Wang G; Liu L; Yi J; Huang Y; Zhang M; Bao Y; Sun L Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008530 [TBL] [Abstract][Full Text] [Related]
11. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma. Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858 [TBL] [Abstract][Full Text] [Related]
12. PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma. Zhou W; Gong L; Wu Q; Xing C; Wei B; Chen T; Zhou Y; Yin S; Jiang B; Xie H; Zhou L; Zheng S J Exp Clin Cancer Res; 2018 Sep; 37(1):215. PubMed ID: 30180906 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN. Zhang QY; Men CJ; Ding XW J Cell Biochem; 2019 Sep; 120(9):14885-14898. PubMed ID: 31044454 [TBL] [Abstract][Full Text] [Related]
14. C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1/2-mediated epithelial-mesenchymal transition. Hu WH; Hu Z; Shen X; Dong LY; Zhou WZ; Yu XX Exp Mol Pathol; 2016 Feb; 100(1):101-8. PubMed ID: 26475622 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of miR-200a suppresses epithelial-mesenchymal transition of liver cancer stem cells. Wang J; Yang X; Ruan B; Dai B; Gao Y; Duan J; Qu S; Tao K; Dou K; Li H Tumour Biol; 2015 Apr; 36(4):2447-56. PubMed ID: 25412960 [TBL] [Abstract][Full Text] [Related]
16. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma. Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875 [TBL] [Abstract][Full Text] [Related]
17. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma. Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103 [TBL] [Abstract][Full Text] [Related]
18. Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma. Qi LN; Xiang BD; Wu FX; Ye JZ; Zhong JH; Wang YY; Chen YY; Chen ZS; Ma L; Chen J; Gong WF; Han ZG; Lu Y; Shang JJ; Li LQ Cancer Res; 2018 Aug; 78(16):4731-4744. PubMed ID: 29915159 [TBL] [Abstract][Full Text] [Related]
19. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway. Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma. Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]